Natco Pharma Limited has informed the Exchange about Schedule of meet
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed the exchanges that its officials will participate in an investor meeting with Aditya Birla Sunlife Mutual Fund on 17th June 2025. The meeting will be held in-person in Hyderabad. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be discussed during the interaction. The disclosure has been made under Regulation 30 of SEBI Listing Regulations. The schedule is subject to change due to exigencies on either side.
This is a routine regulatory disclosure about a one-on-one investor interaction with a mutual fund house and is unlikely to have a material impact on the stock price. It signals normal investor relations activity by the company.